← Open Payments lookup

SIJI SAMUEL: Open Payments

NPI 1801567359 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$563 in 28 payments from 10 companies in 2025. Trend: 2023 $927 · 2024 $527 · 2025 $563

Food & beverage: $563
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$199
Veloxis Pharmaceuticals, Inc.3$91
Alexion Pharmaceuticals, Inc.4$79
NxStage Medical, Inc.2$39
Apellis Pharmaceuticals, Inc.2$33
Otsuka Pharmaceutical Development & Commercialization, Inc.1$29
KYOWA KIRIN, INC.1$25
Ardelyx, Inc.1$25
CorMedix Inc.1$24
Travere Therapeutics, Inc.1$20

Products named: FARXIGA, ENVARSUS, ULTOMIRIS, NXSTAGE SYSTEM ONE, CRYSVITA, IBSRELA, DEFENCATH, Empaveli.

Industry payments across TX — which companies pay providers there.